Drug clinical trial landscape of chronic myeloid leukemia: achieving the endpoint or continuing the journey?

Drug clinical trial landscape of chronic myeloid leukemia: achieving the endpoint or continuing the journey?

Saved in:

Bibliographic Details
Main Authors:	Shiyu Yang, Xia Jiang, Haihui Zhuang, Fenglin Li, Ying Lu
Format:	Article
Language:	English
Published:	BMC 2024-11-01
Series:	Journal of Translational Medicine
Online Access:	https://doi.org/10.1186/s12967-024-05882-5
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

High expression of EBP is an adverse prognostic factor for de novo acute myeloid leukemia
by: Jiaying Lian, et al.
Published: (2024-12-01)

Recurrence of Chronic Myeloid Leukemia during Pregnancy Subsequently Achieving Complete Medical Remission
by: Sasha Mikhael, et al.
Published: (2017-01-01)

IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
by: Tomasz Sacha
Published: (2013-12-01)

TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
by: Michele Baccarani, et al.
Published: (2014-01-01)

Chronic myeloid leukemia following nasopharyngeal carcinoma
by: olfa kassar
Published: (2014-08-01)

Novel targeted therapies in chronic myeloid leukemia
by: Muhammad Sameer Ashaq, et al.
Published: (2024-12-01)

Chronic myeloid leukemia with involvement of membranous labyrinth
by: Mobachir El Kettani, et al.
Published: (2024-01-01)

A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
by: Michele Baccarani, et al.
Published: (2013-12-01)

An interesting case of chronic myeloid leukemia with twists and turns
by: Thulasi Raman Ramalingam, et al.
Published: (2024-12-01)

ONE CASE OF CHRONIC MYELOID LEUKEMIA IN PEDIATRIC GROUP
by: Nihal Boz
Published: (2024-12-01)

Mathematical modeling of cyclic treatments of chronic myeloid leukemia
by: Natalia L. Komarova
Published: (2011-03-01)

The journey Continues
by: Eric M Yoshida, et al.
Published: (2015-01-01)

Design and fabrication of novel microfluidic-based droplets for drug screening on a chronic myeloid leukemia cell line.
by: Niloofar Jaafari, et al.
Published: (2025-01-01)

Delayed manifestation of proliferative retinopathy associated with chronic myeloid leukemia
by: Alan Chew Bonilla, et al.
Published: (2024-12-01)

Prognostic criteria of chronic myeloid leukemia by changes platelets sizes
by: Shorop Y.V., et al.
Published: (2016-03-01)

Prognostic criteria of chronic myeloid leukemia by changes platelets sizes.
by: Y. V. Shorop, et al.
Published: (2016-03-01)

Bone marrow immune cells and drug resistance in acute myeloid leukemia
by: Miao Zhang, et al.
Published: (2025-02-01)

Acute Myeloid Leukemia (AML) With T-Cell Differentiation Arising From Chronic Myelomonocytic Leukemia (CMML)
by: Anthony Crymes, et al.
Published: (2024-01-01)

Extramedullary Manifestations of Chronic Myelomonocytic Leukemia: Do We Treat like an Acute Myeloid Leukemia?
by: Prasun Pudasainee, et al.
Published: (2019-01-01)

Corrigendum to “An Unusual Cause of Bleeding in a Patient with Chronic Myeloid Leukemia Chronic Phase”
by: S. Kartthik, et al.
Published: (2020-01-01)

THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA
by: Francesca Ricci, et al.
Published: (2011-07-01)

THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA
by: Alessandra Tedeschi, et al.
Published: (2011-01-01)

Data and implication based comparison of two chronic myeloid leukemia models
by: R. A. Everett, et al.
Published: (2013-07-01)

Paraneoplastic Autoimmunity Associated with Testicular Myeloid Sarcoma and Chronic Myelomonocytic Leukemia
by: Jeffrey W. Craig, et al.
Published: (2013-01-01)

Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment
by: Zuzana Humlová, et al.
Published: (2010-01-01)

Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells
by: Ahmad Hamad, et al.
Published: (2013-01-01)

Concurrent Diagnosis of Chronic Myeloid Leukemia and Follicular Lymphoma: An Unreported Presentation
by: Amy G. Starr, et al.
Published: (2018-01-01)

Effect of Imatinib on Bone Marrow Morphology and Angiogenesis in Chronic Myeloid Leukemia
by: Neetu Pandey, et al.
Published: (2019-01-01)

Pharmaceutical care and home delivery of medication to patients with chronic myeloid leukemia
by: Begoña San José Ruiz, et al.
Published: (2015-01-01)

Elucidating the immune landscape and potential prognostic model in acute myeloid leukemia with TP53 mutation
by: Gelan Zhu, et al.
Published: (2024-12-01)

Prognostic Significance of Transcript-Type BCR‐ABL1 in Chronic Myeloid Leukemia
by: matteo molica, et al.
Published: (2020-08-01)

Function and mechanism of cancer-testis antigen CT63 in chronic myeloid leukemia
by: KONG Ruxin, et al.
Published: (2024-11-01)

Molecular cloning of EZH2 oncogene in chronic myeloid leukemia and therapeutic prospects
by: Juliana Costa Gaspar, et al.
Published: (2015-07-01)

Modeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft Models
by: Pallavi Sontakke, et al.
Published: (2016-01-01)

Imatinib-resistance without BCR/ABL Point Mutation in Chronic Myeloid Leukemia
by: Aytan Shirinova
Published: (2024-03-01)

Molecular, Cytogenetic, and Hematological Monitoring and Response to Treatment for Chronic Myeloid Leukemia Patients
by: Noor Al-Huda Bahar, et al.
Published: (2024-12-01)

Arterial Occlusive Events in a Patient With Chronic Myeloid Leukemia Treated With Ponatinib
by: Osamu Imataki, et al.
Published: (2024-11-01)

Chronic myeloid leukemia in an asymptomatic young patient: a rare case report
by: Urja Bhatt, et al.
Published: (2024-11-01)

Hyperoside induces ferroptosis in chronic myeloid leukemia cells by targeting NRF2
by: Junyi Wei, et al.
Published: (2024-11-01)

THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA
by: Elvira Pelosi, et al.
Published: (2022-10-01)